CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 69 enrolled
Drug / intervention
External beam radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01417286
NCT01417286Phase 2Completed
CompareCT.gov

Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial

Rutgers, The State University of New Jersey·interventional·Posted Aug 16, 2011·Updated Apr 20, 2023

In Brief

A Phase 2 clinical trial evaluating External beam radiation therapy for Inflammatory Breast Cancer and 9 related conditions. Completed, enrolled 69 participants across 2 sites.

Detailed Summary

This phase II trial studies how well giving accelerated radiation therapy (RT) after surgery works in treating patients with breast cancer. RT uses high energy x rays to kill tumor cells. Giving RT after surgery may kill any remaining tumor cells

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma, Mucinous Ductal Breast Carcinoma, Papillary Ductal Breast Carcinoma, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Tubular Ductal Breast Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI), Rutgers Cancer Institute of New Jersey

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 16, 2011
Enrollment StartDec 21, 2010
Primary CompletionFeb 20, 2020
TodayJul 2, 2026
Enrollment to primary: 9.2 yearsPosted 14.9 years ago

Interventions

External beam radiation therapyradiation

Hypofractionated accelerated radiation therapy over 11 days